Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases

Anticancer Research

Volumn 22, Issue 4, 2002, Pages 1949-1957

  Ree, Anne Hansen ^a   Bratland, Åse ^a   Kroes, Roger A ^a   Aasheim, Hans Christian ^a   Flørenes, Vivi A ^a   Moskal, Joseph R ^a   Fodstad, Øystein ^a   Bruland, Øyvind S ^a   Mælandsmo, Gunhild M ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Central nervous system; Com1; Metastasis; Receptor tyrosine kinases

Indexed keywords

MESSENGER RNA; NUCLEAR FACTOR; PROTEIN; PROTEIN COM1; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL STRAIN MCF 7; CENTRAL NERVOUS SYSTEM METASTASIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CARCINOMA; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RNA ANALYSIS; SIGNAL TRANSDUCTION;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN NEOPLASMS; BREAST NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GLIOMA; HUMANS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0036336214     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Microenvironment revisited: Time for reappraisal of some prevailing concepts of cancer metastasis
2. Modulation of the organ microenvironment for treatment of cancer metastasis
3. General mechanisms of metastasis
4. The role of trophic factors and autocrine/paracrine growth factors in brain metastasis
5. Trophic factors and central nervous system metastasis
6. Expression of a novel factor in human breast cancer cells with metastatic potential
7. Cloning and expression of the rat p8 cDNA, a new gene activated in pancreas during the acute phase of pancreatitis, pancreatic development, and regeneration, and which promotes cellular growth
8. Cloning and expression of the human p 8, a nuclear protein with mitogenic activity
9. Central nervous system metastasis in breast cancer
10. Clinical management of brain metastasis
11. MCF7/LCC2: A 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780
12. 3 and its analogues
13. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia
14. Epithelial cell cultures from normal and cancerous human tissues
15. Establishment and characterization of five cell lines derived from human malignant gliomas
16. A new technique to register proliferation of clonogenic cells from brain tumors
17. Invasiveness of human glioma cell lines in vitro: Relation to tumorigenicity in athymic mice
18. Long term culture of normal and neoplastic human glia
19. Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis
20. Establishment and identification of small cell lung cancer cell lines having classic and variant features
21. Targeted therapy with immunotoxins in a nude rat model for leptomeningeal growth of human small cell lung cancer
22. Phase II preclinical drug screening in human tumor xenografts: A first European multicenter collaborative study
23. A human cell line from a pleural effusion derived from a breast carcinoma
24. Brain metastasis model in athymic nude mice using a novel MUC1-secreting human breast-cancer cell line, MA 11
25. Growth factor independence in vitro of primary melanoma cells from advanced but not early or intermediate lesions
26. Radiolocalization of xenografted human malignant melanoma by a monoclonal antibody (9.2.27) to a melanoma-associated antigen in nude mice
27. Chemosensitivity profiles of human cancers assessed by the 6-day SRC assay on serially xenografted tumors
28. A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX
29. Current concepts in neuro-oncology: The cell cycle - A review
30. 3 in breast cancer cells
31. Expression of a novel factor, com1, in early tumor progression of breast cancer
32. The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells
33. Mitogenic signal transduction in human breast cancer cells
34. Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase
35. Transforming growth factor-β in breast cancer: A working hypothesis
36. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance
37. IGF and insulin action in the mammary gland: Lessons from transgenic and knockout models
38. Oncogenic kinase signalling
39. The EGF receptor family as targets for cancer therapy
40. Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases
41. Biology and treatment of malignant glioma
42. Toward a molecular classification of the gliomas: Histopathology, molecular genetics, and gene expression profiling
43. Molecular changes during the genesis of human gliomas
44. Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells
45. A Grb2-associated docking protein in EGF- and insulin-receptor signalling
46. Transforming growth factor β-1 enhances Smad transcriptional activity through activation of p8 gene expression
47. Brain metastases
48. Multistep nature of metastatic inefficiency. Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases
49. Cancer dormancy: Opportunities for new therapeutic approaches